Vaccine makers have already begun working on second-generation Covid vaccines targeting the new strains of the virus. In South Africa, a more virulent strain has been discovered showing the AstraZeneca vaccine offers only minimal protection against mild to moderate disease and they are racing to adapt its Covid-19 vaccine.